MET and FGFR2 mutation in Metastatic Gastric Cancer. Clinical Implication of Concurrent Amplification of MET and FGFR2 in Metastatic Gastric Cancer

, we analyzed the clinical outcomes of GC patients with MET and FGFR2 amplification using the next-generation sequencing (NGS) database cohort at Samsung Medical Center, which included a total of 2,119 patients between October 2019 and April 2021